adenosine monophosphate has been researched along with Leukemia, Erythroblastic, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comelli, M; Di Pancrazio, F; Mavelli, I | 1 |
| Gardell, SJ; Shi, XP; Yin, KC | 1 |
2 other study(ies) available for adenosine monophosphate and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Apoptosis is induced by decline of mitochondrial ATP synthesis in erythroleukemia cells.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Apoptosis; Catalysis; Cell Line, Tumor; Cell Respiration; Energy Metabolism; Heme; Hydrogen Peroxide; Iron; Lactic Acid; Leukemia, Erythroblastic, Acute; Mice; Mitochondria; Mitochondrial Proton-Translocating ATPases; Oligomycins; Oxidative Stress; Oxygen Consumption; Time Factors | 2003 |
Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Biological Transport; Blood Platelets; Calcium; Humans; Leukemia, Erythroblastic, Acute; Megakaryocytes; Neoplasm Proteins; Neoplastic Stem Cells; Platelet Activation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Thionucleotides; Tumor Cells, Cultured; Uridine Triphosphate | 1995 |